Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV?
- PMID: 24691291
- DOI: 10.1136/gutjnl-2014-306935
Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV?
Keywords: Antiviral Therapy; Cirrhosis; Hepatitis B; Hepatocellular Carcinoma.
Comment on
-
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.Gut. 2014 Dec;63(12):1943-50. doi: 10.1136/gutjnl-2013-306409. Epub 2014 Mar 10. Gut. 2014. PMID: 24615378
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical